149 related articles for article (PubMed ID: 37132366)
1. Nerve-sparing technique in RPLND for testicular cancer.
Nalavenkata S; Li T; Patel MI
Curr Opin Urol; 2023 Jul; 33(4):281-287. PubMed ID: 37132366
[TBL] [Abstract][Full Text] [Related]
2. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
Stepanian S; Patel M; Porter J
Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
[TBL] [Abstract][Full Text] [Related]
3. Intricacies of retroperitoneal lymph node dissection for testis cancer.
Alsyouf M; Daneshmand S
Curr Opin Urol; 2022 Jan; 32(1):24-30. PubMed ID: 34698701
[TBL] [Abstract][Full Text] [Related]
4. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.
Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G
J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537
[TBL] [Abstract][Full Text] [Related]
6. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
[TBL] [Abstract][Full Text] [Related]
7. [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].
Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
Urologe A; 2013 Aug; 52(8):1097-103. PubMed ID: 23416965
[TBL] [Abstract][Full Text] [Related]
8. Robotic-assisted retroperitoneal lymph node dissection for testicular cancer.
Gereta S; Hung M; Hu JC
Curr Opin Urol; 2023 Jul; 33(4):274-280. PubMed ID: 37014761
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal lymph node dissection in testicular cancer.
Jacobsen NE; Foster RS; Donohue JP
Surg Oncol Clin N Am; 2007 Jan; 16(1):199-220. PubMed ID: 17336244
[TBL] [Abstract][Full Text] [Related]
11. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
[TBL] [Abstract][Full Text] [Related]
12. [Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND)].
Nicolai N; Necchi A; Piva L; Stagni S; Catanzaro MA; Biasoni D; Milani A; Torelli T; Salvioni R
Urologia; 2010; 77(2):84-7. PubMed ID: 20890864
[TBL] [Abstract][Full Text] [Related]
13. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
[TBL] [Abstract][Full Text] [Related]
14. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
Heidenreich A; Paffenholz P; Nestler T; Pfister D
Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.
Fankhauser CD; Afferi L; Stroup SP; Rocco NR; Olson K; Bagrodia A; Baky F; Cazzaniga W; Mayer E; Nicol D; Islamoglu E; de Vergie S; Saoud R; Eggener SE; Nazzani S; Nicolai N; Hugar L; Sexton WJ; Matei DV; De Cobelli O; Cheaib J; Pierorazio PM; Porter J; Hermanns T; Hamilton RJ; Hiester A; Albers P; Clarke N; Mattei A
World J Urol; 2022 Jun; 40(6):1505-1512. PubMed ID: 35279732
[TBL] [Abstract][Full Text] [Related]
16. Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.
Pearce S; Steinberg Z; Eggener S
Curr Urol Rep; 2013 Oct; 14(5):511-7. PubMed ID: 23907555
[TBL] [Abstract][Full Text] [Related]
17. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
Werntz RP; Pearce SM; Eggener SE
Curr Opin Urol; 2018 Sep; 28(5):461-468. PubMed ID: 29979235
[TBL] [Abstract][Full Text] [Related]
18. Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.
Małkiewicz B; Świrkosz G; Lewandowski W; Demska K; Szczepaniak Z; Karwacki J; Krajewski W; Szydełko T
Curr Oncol Rep; 2024 Apr; 26(4):318-335. PubMed ID: 38430323
[TBL] [Abstract][Full Text] [Related]
19. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
Mano R; Di Natale R; Sheinfeld J
Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer.
Underwood W; Kim HL
BJU Int; 2012 Jan; 109(2):281-5. PubMed ID: 21631699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
